The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference119 articles.
1. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier cancer research network study GU14-206;Adra;Ann. Oncol.,2018
2. Immune checkpoint inhibition for the treatment of cancers: an update and critical review of ongoing clinical trials;Akhbariyoon;Clin. Immunol.,2021
3. Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC);Amin;J. Clin. Oncol.,2014
4. Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: results of a phase 2 study;Ben-Ami;Cancer,2017
5. Descriptive epidemiological study of rare, less common and common cancers in Western Australia;Bilkey;BMC Cancer,2021
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nivolumab plus ipilimumab with chemotherapy in metastatic NSCLC: minireview and a case study of a patient negative for PD-L1;Drugs in Context;2024-07-19
2. Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer;Translational Oncology;2024-07
3. The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis;Cancers;2024-02-23
4. The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study;Cancer Medicine;2023-12-22
5. Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database;Drugs - Real World Outcomes;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3